Gallic Acid Market Trends

  • Report ID: 5724
  • Published Date: Nov 27, 2025
  • Report Format: PDF, PPT

Gallic Acid Market - Growth Drivers and Challenges

Growth Factors

  • The Use of Gallic Acid as an Astringent in The Cosmetic Industry - Recently, because of its different useful properties, this agent has been acknowledged to be one of the basic phenolic acids of outstanding importance in multiple industries. It is usually utilized as a substance safeguarding against the damaging influence of UV radiation, as caustic in cosmetic arrangements, and as a preservative in food products. Thus, gallic acid is now considered important for human health and industry. More and more better techniques of isolation and assessment are being formed, and new solutions are being sought to raise its generation. During the first decade of the 21st century, complete beauty and individual care materials increased from 166.1 billion USD to 382.3 billion with a 25.9% revenue share of Asia.

  • Highly Effective Component - Multiple advantageous impacts are reported for gallic acid, comprising antioxidant, anti-inflammatory, and antineoplastic qualities. This mixture has been reported to have curative activities in gastrointestinal, neuropsychological, metabolic, and cardiovascular diseases. Gallic acid may assist regulate your immune system and work as a natural defense mechanism as opposed to microbial infections (5Trusted Source). One study made a creative light-increased antimicrobial treatment by discovering gallic acid to ultraviolet-C (UV-C) light. The sun emits this kind of unseen ultraviolet light, and it’s usually implemented as an antiseptic (6Trusted Source). The resulting antimicrobial activity was substantial. The authors recommended that gallic acid discovered in UV-C light has the possibility as a new antimicrobial treatment in the food system.

  • It Is Vastly Used as an Anti-Obesity Component - In one review, researchers investigated the anti-obesity properties of gallic acid. Particularly, it emerges to secure against inflammation and oxidative anxiety that can emerge among people with obesity. Some studies recommend that gallic acid limits too much fat storage in people with obesity by withholding lipogenesis. Lipogenesis is the synthesis of fat from agents like sugars inside your body. The agent may also modify insulin signaling and limit oxidative stress and inflammation.

Challenges

  • Lack of Availability of Gallic The function of this review is to clear up the pharmacological activities and associated molecular mechanisms of GA in inflammatory diseases. After advisory a large number of literature, people made an all-inclusive demonstration on the chemical traits, plant origins, pharmacokinetics, and toxicity of GA, specifically its pharmacological operations, and mechanisms of action. Although the plant source of GA is very deep, its lower origin rate restricts the application of GA in growth. It is usually implemented as a substance securing against the damaging influences of UV radiation, a caustic in cosmetic preparations, and a preservative in food products. Thus, gallic acid is now considered vital for both human health and industry.
  • Demand and Supply Gap for The Product
  • Rising Requirement for Substitute Products

Base Year

2025

Forecast Year

2026-2035

CAGR

5.2%

Base Year Market Size (2025)

USD 88.93 million

Forecast Year Market Size (2035)

USD 147.64 million

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of gallic acid is estimated at USD 93.09 million.

The global gallic acid market size was more than USD 88.93 million in 2025 and is anticipated to grow at a CAGR of over 5.2%, reaching USD 147.64 million revenue by 2035.

By 2035, the Asia Pacific gallic acid market is anticipated to secure a 42% revenue share during 2026-2035, supported by escalating cardiovascular disease prevalence across the region.

Key players in the market include Wego Chemical Group, GALLOCHEM Co., Ltd., CDH Fine Chemicals, TCI Chemicals, Sigma Aldrich, Cayman Chemicals, Jiurui Biology, Bei Yuan, Chemical, Hunan Linong, Tianxin Biotech, Air Liquide Japan G.K, Air Water Performance Chemical Inc., Adeka Corporation, Celanese Japan Limited.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos